Mitochondrial‑DNA‑associated TLR9 signalling is a potential serological biomarker for non‑small cell lung cancer

  • Authors:
    • Yu‑Heng Lai
    • Hao‑Yun Liu
    • Chun‑Yao Huang
    • Yat‑Pang Chau
    • Semon Wu
  • View Affiliations

  • Published online on: November 9, 2018     https://doi.org/10.3892/or.2018.6855
  • Pages: 999-1006
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Mitochondrial (mt) DNA has been long suggested to contribute to carcinogenesis, and a variety of mutations in mtDNA have been confirmed to be related to various early stages of cancers; these data revealed that the detection of mtDNA in clinical samples may be a promising approach for cancer diagnosis. In the present study, the serum mtDNA in healthy donors and groups of patients with cancer was detected. It was revealed that patients with lung cancer without metastasis had more mtDNA in serum compared to patients with metastasis. Moreover, TLR9‑associated signalling was activated in vitro after treatment with a synthetic CpG oligodeoxyribonucleotide (ODN) called ODN‑M362. In addition, our data revealed that TLR9 and its adaptor protein, MyD88, were induced by ODN‑M362 in a dose‑dependent manner. A human cytokine array to evaluate stimulation of cytokine secretion by ODN‑M362 was also used. Our findings may identify the role that TLR9 and mtDNA play in lung cancer progression and metastasis.
View Figures
View References

Related Articles

Journal Cover

February-2019
Volume 41 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lai YH, Liu HY, Huang CY, Chau YP and Wu S: Mitochondrial‑DNA‑associated TLR9 signalling is a potential serological biomarker for non‑small cell lung cancer. Oncol Rep 41: 999-1006, 2019.
APA
Lai, Y., Liu, H., Huang, C., Chau, Y., & Wu, S. (2019). Mitochondrial‑DNA‑associated TLR9 signalling is a potential serological biomarker for non‑small cell lung cancer. Oncology Reports, 41, 999-1006. https://doi.org/10.3892/or.2018.6855
MLA
Lai, Y., Liu, H., Huang, C., Chau, Y., Wu, S."Mitochondrial‑DNA‑associated TLR9 signalling is a potential serological biomarker for non‑small cell lung cancer". Oncology Reports 41.2 (2019): 999-1006.
Chicago
Lai, Y., Liu, H., Huang, C., Chau, Y., Wu, S."Mitochondrial‑DNA‑associated TLR9 signalling is a potential serological biomarker for non‑small cell lung cancer". Oncology Reports 41, no. 2 (2019): 999-1006. https://doi.org/10.3892/or.2018.6855